Olive Raises $51M In General Catalyst-Led Round To Create ‘The AI Workforce For Health Care’

To say hospitals are overloaded right now is an understatement. Doctors and nurses are overwhelmed addressing the COVID-19 pandemic, not just in treating those patients but also in helping prevent it from spreading or trying to avoid getting it themselves. Subscribe to the Crunchbase Daily One Columbus, Ohio-based startup that

Meet the 26 healthcare startups that top VCs say are poised to take off amid the coronavirus pandemic

Business Insider asked 13 top venture capital investors which startups they think will thrive despite the coronavirus pandemic, and why. We asked them to pick two companies, including one they’re not invested in. Their answers span from telehealth to virtual clinics to machine-learning-inspired heart scans. Visit Business Insider’s homepage for

Univfy to Present at Digital Medicine & Medtech Showcase 2020 on How AI and Fintech Make IVF Easier to Navigate for Patients and Providers

LOS ALTOS, Calif., Dec. 9, 2019 /PRNewswire/ — Univfy®, an AI and machine learning platform company with a mission to expand access to in-vitro fertilization (IVF), announced that Dr. Mylene Yao, cofounder and CEO, will be presenting at the upcoming conferences: Digital Medicine & Medtech Showcase 2020: When: Jan. 14, 2020 | 9:00 a.m. PTWhere: Parc 55 San

Univfy to Speak at ACG New York Women of Leadership Summit and European HealthTech CEO Forum About Future of FemTech and HealthTech

LOS ALTOS, Calif., Jan. 9, 2020 /PRNewswire/ — Univfy, an AI platform company with a mission to expand access to in vitro fertilization (IVF), announced that cofounder and CEO Mylene Yao will be speaking at the upcoming conferences: ACG New York Women of Leadership Summit When: Jan. 16, 2020 | 12:00 p.m. ETWhere: 111 East 48th St. New York, NY 10017What: FemTech Panel to

BrainStorm Cell Therapeutics to Present at the 2019 NobleCon15 Annual Investor Conference in Fort Lauderdale, Florida

From Startup Brainstorm Cell Therapeutics Link to Full Article: http://ir.brainstorm-cell.com/phoenix.zhtml?c=142287&p=irol-newsArticle&ID=2384849 NEW YORK, Jan. 25, 2019 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today that Chaim Lebovits, CEO will provide a corporate overview presentation at

Basilea Announces Collaboration to Study Derazantinib & Atezolizumab (Tecentriq®) in Urothelial Cancer

From Startup ARQULE Link to Full Article: BURLINGTON, Mass.–(BUSINESS WIRE)–Jan. 24, 2019– ArQule, Inc.’s (Nasdaq: ARQL) partner, Basilea Pharmaceutica Ltd. (SIX: BSLN), announced today that it entered into a collaboration with Roche (SIX: RO, ROG) to explore a combination of derazantinib (BAL087) and Roche’s PD-L1-blocking immune-checkpoint inhibitor, atezolizumab (Tecentriq®), in

Reflections on the PMSA Winter Symposium

From Startup prognos Link to Full Article: By Theresa Greco, Chief Commercial Officer The PMSA Winter Symposium, “Innovation in Analytics via Machine Learning & AI” brought together industry leaders in data science and analytics to share experience and knowledge on real world applications of ML/AI within Life Sciences.  Expert speakers

BrainStorm Granted Additional Patent for NurOwn® in Israel

From Startup Brainstorm Cell Therapeutics Link to Full Article: http://ir.brainstorm-cell.com/phoenix.zhtml?c=142287&p=irol-newsArticle&ID=2384331 NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for debilitating neurodegenerative diseases, today announced that the Israel Patent Office has granted an additional patent titled “Methods